VIVUS, Inc. (NASDAQ:VVUS) on Feb. 24 provided a business update and reported its financial results for the fourth quarter and year ended December 31, 2013. For the fourth quarter of 2013, total net product revenue was $9.2 million, of which $7.7 million was from sales of Qsymia and the remaining amount was from STENDRA and SPEDRA. VIVUS, Inc. (NASDAQ:VVUS) stock opened at $5.94 in last session, and closed at $5.85, while the day range of stock is $5.63 – $ 5.94. The stock showed a negative weekly performance of -13.97%.
UTi Worldwide Inc. (NASDAQ:UTIW) announced that it has priced its private offering of $350 million aggregate principal amount of 4.50% Convertible Senior Notes due 2019 (the “Notes”). UTi Worldwide Inc. (“UTi”) has also granted the initial purchasers in the offering an option to purchase up to an additional $50 million aggregate principal amount of the Notes. UTi Worldwide Inc. (NASDAQ:UTIW) stock opened at $12.07, in last session and closed at $10.74, by losing -29.62%. The 52 week range of the stock is $10.72 – $ 17.70. Company’s market capitalization is $1.13 billion.
Joseph Eazor, CEO of communications, IT, and network services provider EarthLink Holdings Corp (NASDAQ:ELNK), bought 64,600 shares of company stock for $250,829. Earthlink Holdings Corp (NASDAQ:ELNK) stock decreased -3.00% and finished the last session at $3.88. The EPS of the stock remained -2.51. Company’s market capitalization is $395.28 million.
Analysts at William Blair downgraded shares of Ventrus Biosciences Inc (NASDAQ:VTUS) from an “outperform” rating to a “market perform” rating in a research note on Wednesday, February 12th. Ventrus Biosciences Inc (NASDAQ:VTUS) stock opened the session at $1.47, and closed the session at $1.39. The 52 week range of the stock remained $1.38 – $ 4.69 and the day range was $1.38 – $1.48.